DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Reyataz (Atazanavir) - Foetal Exposure During Pregnancy - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Foetal Exposure During Pregnancy (102)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Reyataz (Atazanavir) where reactions include foetal exposure during pregnancy. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 102   Next >>

Possible Reyataz side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27

Patient:

Reactions: Foetal Chromosome Abnormality, Spina Bifida, Foetal Exposure During Pregnancy, Arnold-Chiari Malformation, Vertical Talus

Drug(s) suspected as cause:
Truvada
    Dosage: 1 df, unk
    Start date: 2011-07-13
    End date: 2011-10-27

Reyataz
    Dosage: 300 mg, qd
    Start date: 2011-07-13
    End date: 2011-10-27

Combivir
    Dosage: 2 df, unk
    Start date: 2011-11-21

Norvir
    Dosage: 100 mg, qd
    Start date: 2011-07-13
    End date: 2011-10-27

Isentress
    Dosage: 800 mg, qd
    Start date: 2011-11-21



Possible Reyataz side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24

Patient: male

Reactions: Congenital Bladder Anomaly, Urethral Valves, Congenital Hydronephrosis, Foetal Exposure During Pregnancy, Bladder Obstruction, Congenital Renal Disorder

Drug(s) suspected as cause:
Lisinopril
    Indication: Maternal Exposure Timing Unspecified

Retrovir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Atorvastatin
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in

Reported by a physician from United States on 2012-08-23

Patient: , weighing 1.9 kg (4.2 pounds)

Reactions: Foetal Exposure During Pregnancy, Congenital Foot Malformation

Drug(s) suspected as cause:
Norvir
    Dosage: 100mgd per day
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27

Truvada
    Dosage: 1tab per day
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27

Combivir
    Dosage: 2tab per day
    Indication: Antiretroviral Therapy
    Start date: 2011-11-21

Raltegravir
    Dosage: 800mgd per day
    Indication: Antiretroviral Therapy
    Start date: 2011-11-21

Reyataz
    Dosage: 300mgd per day
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27



Possible Reyataz side effects in male

Reported by a physician from France on 2012-08-21

Patient: male

Reactions: Dysmorphism, Foetal Exposure During Pregnancy, Renal Dysplasia, Intestinal Malrotation, Persistent Cloaca, Trisomy 21, Bladder Dilatation, Cleft Palate, Protrusion Tongue, Renal Aplasia, LOW SET Ears, Abdominal Distension, Anal Atresia, Eagle Barrett Syndrome

Adverse event resulted in: death

Drug(s) suspected as cause:
Reyataz
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17

Patient: male, weighing 3.7 kg (8.2 pounds)

Reactions: Hydronephrosis, Foetal Exposure During Pregnancy, Congenital Megaureter, Pyelocaliectasis

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified

Retrovir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Combivir
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in male

Reported by a physician from United States on 2012-08-17

Patient: male, weighing 3.7 kg (8.1 pounds)

Reactions: Hydronephrosis, Foetal Exposure During Pregnancy, Congenital Megaureter, Pyelocaliectasis

Drug(s) suspected as cause:
Truvada
    Dosage: 1tab per day
    Indication: Antiretroviral Therapy
    End date: 2011-11-10

Combivir
    Dosage: 2tab per day
    Indication: Antiretroviral Therapy
    Start date: 2011-11-10
    End date: 2012-06-07

Norvir
    Dosage: 100mgd per day
    Indication: Antiretroviral Therapy

Reyataz
    Dosage: 300mgd per day
    Indication: Antiretroviral Therapy

Other drugs received by patient: Retrovir; Fluconazole; Terazol Cream; Retrovir; Unspecified Medication



Possible Reyataz side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17

Patient: female, weighing 3.7 kg (8.1 pounds)

Reactions: Neurofibromatosis, Foetal Exposure During Pregnancy, Cafe AU Lait Spots

Drug(s) suspected as cause:
Truvada

Norvir
    Indication: Maternal Exposure Timing Unspecified

Reyataz



Possible Reyataz side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17

Patient:

Reactions: Foetal Exposure During Pregnancy, Congenital Anomaly, Abortion Spontaneous

Adverse event resulted in: death

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in female

Reported by a physician from France on 2012-08-17

Patient: female

Reactions: Foetal Exposure During Pregnancy, Congenital Central Nervous System Anomaly, Abortion Induced, Congenital Absence of Cranial Vault

Adverse event resulted in: death

Drug(s) suspected as cause:
Truvada
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-15

Patient: female

Reactions: Foetal Exposure During Pregnancy, Congenital Genital Malformation Female

Drug(s) suspected as cause:
Prezista
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-14

Patient:

Reactions: Hypoplastic Left Heart Syndrome, Foetal Exposure During Pregnancy, Stillbirth, Heart Disease Congenital

Adverse event resulted in: death

Drug(s) suspected as cause:
Reyataz
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Product Used FOR Unknown Indication



Possible Reyataz side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-14

Patient:

Reactions: Cytogenetic Abnormality, Premature Baby, Foetal Exposure During Pregnancy, Hypoxia, Limb Malformation, Cerebral Haemorrhage, Genetic Polymorphism

Adverse event resulted in: death

Drug(s) suspected as cause:
Truvada
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient:

Reactions: Foetal Chromosome Abnormality, Spina Bifida, Foetal Exposure During Pregnancy, Arnold-Chiari Malformation, Vertical Talus

Drug(s) suspected as cause:
Truvada
    Dosage: 1 df, unk
    Start date: 2011-07-13
    End date: 2011-10-27

Combivir
    Dosage: 2 df, unk
    Start date: 2011-11-21

Norvir
    Dosage: 100 mg, qd
    Start date: 2011-07-13
    End date: 2011-10-27

Reyataz
    Dosage: 300 mg, qd
    Start date: 2011-07-13
    End date: 2011-10-27

Isentress
    Dosage: 800 mg, qd
    Start date: 2011-11-21



Possible Reyataz side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient: male

Reactions: Urethral Valves, Congenital Bladder Anomaly, Congenital Hydronephrosis, Foetal Exposure During Pregnancy, Bladder Obstruction, Congenital Renal Disorder

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Retrovir
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-09

Patient: male, weighing 3.1 kg (6.8 pounds)

Reactions: Foetal Exposure During Pregnancy, Naevus Flammeus

Drug(s) suspected as cause:
Truvada
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-09

Patient: male, weighing 3.1 kg (6.8 pounds)

Reactions: Foetal Exposure During Pregnancy, Naevus Flammeus

Drug(s) suspected as cause:
Truvada
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in male

Reported by a physician from France on 2012-08-08

Patient: male

Reactions: Foetal Exposure During Pregnancy, Haemangioma Congenital

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-07

Patient: male, weighing 3.1 kg (6.8 pounds)

Reactions: Foetal Exposure During Pregnancy, Naevus Flammeus

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-07

Patient: , weighing 1.9 kg (4.2 pounds)

Reactions: Foetal Exposure During Pregnancy, Congenital Foot Malformation

Drug(s) suspected as cause:
Truvada
    Dosage: 1tab per day
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27

Reyataz
    Dosage: 300mgd per day
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27

Combivir
    Dosage: 2tab per day
    Indication: Antiretroviral Therapy
    Start date: 2011-11-21

Raltegravir
    Dosage: 800mgd per day
    Indication: Antiretroviral Therapy
    Start date: 2011-11-21

Norvir
    Dosage: 100mgd per day
    Indication: Antiretroviral Therapy
    Start date: 2011-07-13
    End date: 2011-10-27



Possible Reyataz side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-06

Patient: male

Reactions: Urethral Valves, Congenital Bladder Anomaly, Congenital Hydronephrosis, Foetal Exposure During Pregnancy, Bladder Obstruction, Congenital Renal Disorder

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Retrovir
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in male

Reported by a physician from France on 2012-08-03

Patient: male

Reactions: Foetal Exposure During Pregnancy, Haemangioma Congenital

Drug(s) suspected as cause:
Reyataz
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in female

Reported by a pharmacist from Canada on 2012-08-03

Patient: female

Reactions: Microcephaly, Foetal Exposure During Pregnancy, Infantile Spasms

Drug(s) suspected as cause:
Norvir
    Indication: Product Used FOR Unknown Indication

Truvada
    Indication: Product Used FOR Unknown Indication

Reyataz
    Indication: Product Used FOR Unknown Indication



Possible Reyataz side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-02

Patient: male, weighing 3.7 kg (8.2 pounds)

Reactions: Hydronephrosis, Foetal Exposure During Pregnancy, Congenital Megaureter, Pyelocaliectasis

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Combivir
    Indication: Maternal Exposure Timing Unspecified

Retrovir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-02

Patient: male, weighing 3.1 kg (6.8 pounds)

Reactions: Foetal Exposure During Pregnancy, Naevus Flammeus

Drug(s) suspected as cause:
Norvir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-02

Patient: male, weighing 3.1 kg (6.8 pounds)

Reactions: Foetal Exposure During Pregnancy, Naevus Flammeus

Drug(s) suspected as cause:
Reyataz
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in male

Reported by a physician from France on 2012-07-30

Patient: male

Reactions: Foetal Exposure During Pregnancy, Intestinal Malrotation, Renal Dysplasia, Persistent Cloaca, Trisomy 21, Cleft Palate, Bladder Dilatation, Protrusion Tongue, Amniotic Fluid Volume Decreased, Renal Aplasia, LOW SET Ears, Abdominal Distension, Anal Atresia, Eagle Barrett Syndrome

Adverse event resulted in: death

Drug(s) suspected as cause:
Reyataz
    Indication: Maternal Exposure Timing Unspecified
    Start date: 2012-01-24

Norvir
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-26

Patient: male

Reactions: Alpha 1 Foetoprotein Abnormal, Foetal Exposure During Pregnancy

Drug(s) suspected as cause:
Truvada
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-25

Patient: male

Reactions: Urethral Valves, Congenital Bladder Anomaly, Congenital Hydronephrosis, Foetal Exposure During Pregnancy, Bladder Obstruction, Congenital Renal Disorder

Drug(s) suspected as cause:
Reyataz
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified

Retrovir
    Indication: Maternal Exposure Timing Unspecified

Truvada
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-23

Patient: male

Reactions: Alpha 1 Foetoprotein Abnormal, Foetal Exposure During Pregnancy

Drug(s) suspected as cause:
Truvada
    Indication: Maternal Exposure Timing Unspecified

Norvir
    Indication: Maternal Exposure Timing Unspecified

Reyataz
    Indication: Maternal Exposure Timing Unspecified



Possible Reyataz side effects in male

Reported by a physician from United States on 2012-07-23

Patient: male

Reactions: Hydronephrosis, Foetal Exposure During Pregnancy, Congenital Megaureter, Pyelocaliectasis

Drug(s) suspected as cause:
Truvada
    Dosage: 1tab per day
    Indication: Antiretroviral Therapy
    End date: 2011-11-10

Combivir
    Dosage: 2tab per day
    Indication: Antiretroviral Therapy
    Start date: 2011-11-10
    End date: 2012-06-07

Norvir
    Dosage: 100mgd per day
    Indication: Antiretroviral Therapy

Reyataz
    Dosage: 300mgd per day
    Indication: Antiretroviral Therapy

Other drugs received by patient: Unspecified Medication; Terazol Cream; Retrovir; Fluconazole; Retrovir



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017